

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 8.34418365 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 7.23606167 |
| 3 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 5.84748141 |
| 4 | endothelium development (GO:0003158) | 5.61647755 |
| 5 | angiogenesis involved in wound healing (GO:0060055) | 5.32935348 |
| 6 | surfactant homeostasis (GO:0043129) | 5.30741385 |
| 7 | heart trabecula formation (GO:0060347) | 5.08911145 |
| 8 | cardiac myofibril assembly (GO:0055003) | 4.80804222 |
| 9 | positive regulation of vasculogenesis (GO:2001214) | 4.78401371 |
| 10 | morphogenesis of an endothelium (GO:0003159) | 4.72156396 |
| 11 | endothelial tube morphogenesis (GO:0061154) | 4.72156396 |
| 12 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.59000994 |
| 13 | blood vessel maturation (GO:0001955) | 4.55735741 |
| 14 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.51673388 |
| 15 | * lymphangiogenesis (GO:0001946) | 4.47351465 |
| 16 | sarcomere organization (GO:0045214) | 4.46588142 |
| 17 | Notch signaling involved in heart development (GO:0061314) | 4.42772007 |
| 18 | regulation of vasculogenesis (GO:2001212) | 4.31908049 |
| 19 | chemical homeostasis within a tissue (GO:0048875) | 4.22787724 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.21724478 |
| 21 | regulation of endothelial cell differentiation (GO:0045601) | 4.19246732 |
| 22 | transcytosis (GO:0045056) | 4.16223632 |
| 23 | basement membrane organization (GO:0071711) | 4.14117700 |
| 24 | plasma membrane repair (GO:0001778) | 4.11691603 |
| 25 | myofibril assembly (GO:0030239) | 4.08036605 |
| 26 | regulation of blood vessel endothelial cell migration (GO:0043535) | 4.01002289 |
| 27 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.84309219 |
| 28 | venous blood vessel morphogenesis (GO:0048845) | 3.74768428 |
| 29 | patterning of blood vessels (GO:0001569) | 3.71320822 |
| 30 | sprouting angiogenesis (GO:0002040) | 3.69259975 |
| 31 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.69127083 |
| 32 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.65161318 |
| 33 | * embryonic heart tube development (GO:0035050) | 3.60943171 |
| 34 | trabecula formation (GO:0060343) | 3.57108129 |
| 35 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.52252983 |
| 36 | regulation of cardioblast differentiation (GO:0051890) | 3.52091761 |
| 37 | positive regulation of protein kinase C signaling (GO:0090037) | 3.42340934 |
| 38 | negative regulation of epithelial cell migration (GO:0010633) | 3.38226341 |
| 39 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.37536821 |
| 40 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.36797356 |
| 41 | regulation of actin filament-based movement (GO:1903115) | 3.36502933 |
| 42 | endothelial cell morphogenesis (GO:0001886) | 3.31227942 |
| 43 | * endothelial cell differentiation (GO:0045446) | 3.29827564 |
| 44 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.27260577 |
| 45 | cardiac muscle cell development (GO:0055013) | 3.22017041 |
| 46 | muscle filament sliding (GO:0030049) | 3.20045958 |
| 47 | actin-myosin filament sliding (GO:0033275) | 3.20045958 |
| 48 | * vasculogenesis (GO:0001570) | 3.19934780 |
| 49 | cell migration involved in heart development (GO:0060973) | 3.19287182 |
| 50 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.18936744 |
| 51 | wound healing, spreading of epidermal cells (GO:0035313) | 3.15756152 |
| 52 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.15675586 |
| 53 | endothelial cell proliferation (GO:0001935) | 3.15426236 |
| 54 | cardiac muscle contraction (GO:0060048) | 3.15368671 |
| 55 | positive regulation of glomerulus development (GO:0090193) | 3.14892730 |
| 56 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.14382802 |
| 57 | fatty acid transmembrane transport (GO:1902001) | 3.12953226 |
| 58 | carnitine shuttle (GO:0006853) | 3.11796207 |
| 59 | low-density lipoprotein particle clearance (GO:0034383) | 3.11120831 |
| 60 | actomyosin structure organization (GO:0031032) | 3.10542727 |
| 61 | cardiac cell development (GO:0055006) | 3.09888894 |
| 62 | positive regulation of odontogenesis (GO:0042482) | 3.08180102 |
| 63 | glomerular filtration (GO:0003094) | 3.08167796 |
| 64 | muscle tissue morphogenesis (GO:0060415) | 3.08065002 |
| 65 | nephron epithelium development (GO:0072009) | 3.06933860 |
| 66 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.06793093 |
| 67 | regulation of glomerular filtration (GO:0003093) | 3.05449911 |
| 68 | negative regulation of focal adhesion assembly (GO:0051895) | 3.05361158 |
| 69 | negative regulation of cell junction assembly (GO:1901889) | 3.05361158 |
| 70 | negative regulation of adherens junction organization (GO:1903392) | 3.05361158 |
| 71 | regulation of endothelial cell migration (GO:0010594) | 3.05156075 |
| 72 | * blood vessel endothelial cell migration (GO:0043534) | 3.03807028 |
| 73 | negative regulation of angiogenesis (GO:0016525) | 3.02498525 |
| 74 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.01662262 |
| 75 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.00637828 |
| 76 | regulation of vascular permeability (GO:0043114) | 2.99432029 |
| 77 | renal filtration (GO:0097205) | 2.98990788 |
| 78 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.98518712 |
| 79 | coronary vasculature morphogenesis (GO:0060977) | 2.97387266 |
| 80 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.96413188 |
| 81 | regulation of sarcomere organization (GO:0060297) | 2.94956588 |
| 82 | regulation of sequestering of triglyceride (GO:0010889) | 2.92486396 |
| 83 | cardiac muscle cell proliferation (GO:0060038) | 2.91363721 |
| 84 | apoptotic process involved in morphogenesis (GO:0060561) | 2.90591548 |
| 85 | cardiac muscle hypertrophy (GO:0003300) | 2.90184471 |
| 86 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.88729130 |
| 87 | negative regulation of endothelial cell migration (GO:0010596) | 2.87722823 |
| 88 | adult heart development (GO:0007512) | 2.87621833 |
| 89 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.87337097 |
| 90 | positive regulation of urine volume (GO:0035810) | 2.84731579 |
| 91 | regulation of synapse maturation (GO:0090128) | 2.84681866 |
| 92 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.84308013 |
| 93 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.83511545 |
| 94 | cAMP biosynthetic process (GO:0006171) | 2.83226871 |
| 95 | heart valve formation (GO:0003188) | 2.82538830 |
| 96 | labyrinthine layer development (GO:0060711) | 2.82097120 |
| 97 | adherens junction assembly (GO:0034333) | 2.81985537 |
| 98 | ovulation from ovarian follicle (GO:0001542) | 2.80464182 |
| 99 | negative regulation of vasculature development (GO:1901343) | 2.79853135 |
| 100 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.79342389 |
| 101 | tricarboxylic acid cycle (GO:0006099) | 2.79038933 |
| 102 | aorta morphogenesis (GO:0035909) | 2.78338700 |
| 103 | regulation of skeletal muscle contraction (GO:0014819) | 2.78148805 |
| 104 | negative regulation of platelet activation (GO:0010544) | 2.77641059 |
| 105 | atrioventricular valve morphogenesis (GO:0003181) | 2.77501613 |
| 106 | potassium ion import (GO:0010107) | 2.77432905 |
| 107 | hyaluronan catabolic process (GO:0030214) | 2.77403000 |
| 108 | Notch receptor processing (GO:0007220) | 2.76970247 |
| 109 | semaphorin-plexin signaling pathway (GO:0071526) | 2.76156098 |
| 110 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.75336941 |
| 111 | heart trabecula morphogenesis (GO:0061384) | 2.75289531 |
| 112 | regulation of p38MAPK cascade (GO:1900744) | 2.73996824 |
| 113 | cell volume homeostasis (GO:0006884) | 2.73659763 |
| 114 | regulation of the force of heart contraction (GO:0002026) | 2.72963932 |
| 115 | striated muscle hypertrophy (GO:0014897) | 2.72428428 |
| 116 | actin-mediated cell contraction (GO:0070252) | 2.70197204 |
| 117 | blood vessel morphogenesis (GO:0048514) | 2.69482066 |
| 118 | cell proliferation involved in metanephros development (GO:0072203) | 2.69150068 |
| 119 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.69070194 |
| 120 | trabecula morphogenesis (GO:0061383) | 2.68821367 |
| 121 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.67704279 |
| 122 | regulation of urine volume (GO:0035809) | 2.65921238 |
| 123 | endothelial cell chemotaxis (GO:0035767) | 2.65591500 |
| 124 | * angiogenesis (GO:0001525) | 2.65341971 |
| 125 | negative regulation of vascular permeability (GO:0043116) | 2.65228190 |
| 126 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.62905278 |
| 127 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62832167 |
| 128 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.62636417 |
| 129 | blood vessel remodeling (GO:0001974) | 2.61715439 |
| 130 | heart morphogenesis (GO:0003007) | 2.60812835 |
| 131 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.59253421 |
| 132 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.59016667 |
| 133 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.57477750 |
| 134 | axon extension involved in axon guidance (GO:0048846) | 2.57477750 |
| 135 | regulation of fatty acid oxidation (GO:0046320) | 2.57429956 |
| 136 | NADH metabolic process (GO:0006734) | 2.57097026 |
| 137 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.56097452 |
| 138 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.55885462 |
| 139 | positive regulation of cell junction assembly (GO:1901890) | 2.55741455 |
| 140 | positive regulation of focal adhesion assembly (GO:0051894) | 2.55741455 |
| 141 | glomerular basement membrane development (GO:0032836) | 2.55549265 |
| 142 | negative regulation of myoblast differentiation (GO:0045662) | 2.55441529 |
| 143 | gap junction assembly (GO:0016264) | 2.55068466 |
| 144 | positive regulation of endothelial cell migration (GO:0010595) | 2.53904383 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.51493949 |
| 146 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.51493949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.25407426 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.72330830 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.98518112 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.97708730 |
| 5 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.89237342 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.88812353 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.82419411 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.78163134 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.66885513 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46924445 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.42218720 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.42218720 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.37946350 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22531335 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13344189 |
| 16 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.12021257 |
| 17 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.09911200 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.09319177 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00734164 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.94904679 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.94101813 |
| 22 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88327301 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87151857 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85224574 |
| 25 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84160911 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71590219 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70721991 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.69993128 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69269147 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69074784 |
| 31 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63838968 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63464017 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61970964 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55357605 |
| 35 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54748126 |
| 36 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51195245 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50788595 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49366785 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45853109 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43240161 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42290514 |
| 42 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.41275685 |
| 43 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40101434 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39886999 |
| 45 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38447505 |
| 46 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.38434630 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37128890 |
| 48 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35250575 |
| 49 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35250575 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34582464 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34374702 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.33730219 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33287999 |
| 54 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.33172146 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31556598 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31277265 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28950279 |
| 58 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.27975203 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27844916 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24507523 |
| 61 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.22551701 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21957016 |
| 63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21706165 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20660660 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18485913 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16810330 |
| 67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16575216 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15929725 |
| 69 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15653427 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15398543 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14926321 |
| 72 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14790823 |
| 73 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12635656 |
| 74 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.12341757 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12162915 |
| 76 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.12101248 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12003863 |
| 78 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11532345 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11047858 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10405994 |
| 81 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09942698 |
| 82 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09288856 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08958827 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08728424 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08586449 |
| 86 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07781102 |
| 87 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.07543545 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06688652 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06418363 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06406742 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05520298 |
| 92 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04994306 |
| 93 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.04912795 |
| 94 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.04526456 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04215656 |
| 96 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03411385 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03130014 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01995857 |
| 99 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01937852 |
| 100 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01735634 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01342743 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00649855 |
| 103 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99787726 |
| 104 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99580365 |
| 105 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98655445 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98509877 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98304986 |
| 108 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97436252 |
| 109 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96311993 |
| 110 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96228308 |
| 111 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95270886 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95124403 |
| 113 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.95041989 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94840707 |
| 115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94574986 |
| 116 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94451928 |
| 117 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.92618126 |
| 118 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91790921 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91630056 |
| 120 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90646744 |
| 121 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89744163 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89598179 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89404990 |
| 124 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88949237 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86853284 |
| 126 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85918245 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85086152 |
| 128 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83881662 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81940341 |
| 130 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.81895563 |
| 131 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.81725338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.81735852 |
| 2 | * MP0001879_abnormal_lymphatic_vessel | 4.71485481 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.02853876 |
| 4 | MP0004272_abnormal_basement_membrane | 3.89187383 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.48694595 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 3.43207377 |
| 7 | MP0006054_spinal_hemorrhage | 3.41922016 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.30786767 |
| 9 | MP0000751_myopathy | 3.10142249 |
| 10 | MP0003828_pulmonary_edema | 2.73777818 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.72809358 |
| 12 | MP0006138_congestive_heart_failure | 2.59873227 |
| 13 | MP0003724_increased_susceptibility_to | 2.59159447 |
| 14 | MP0005330_cardiomyopathy | 2.48434910 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.38779933 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.22607180 |
| 17 | MP0005385_cardiovascular_system_phenoty | 2.22607180 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.18191161 |
| 19 | MP0003646_muscle_fatigue | 2.07635958 |
| 20 | MP0003279_aneurysm | 2.06359478 |
| 21 | MP0002972_abnormal_cardiac_muscle | 2.06335006 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.00666174 |
| 23 | MP0004130_abnormal_muscle_cell | 1.93860003 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.90886961 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.83118690 |
| 26 | MP0000749_muscle_degeneration | 1.82644221 |
| 27 | MP0000767_abnormal_smooth_muscle | 1.82471128 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.77471493 |
| 29 | MP0004085_abnormal_heartbeat | 1.72355631 |
| 30 | MP0005620_abnormal_muscle_contractility | 1.70678019 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.69324334 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.68481378 |
| 33 | MP0004484_altered_response_of | 1.67855695 |
| 34 | MP0005670_abnormal_white_adipose | 1.67619452 |
| 35 | MP0001958_emphysema | 1.57568475 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.52514766 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.50488244 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.46235738 |
| 39 | MP0003137_abnormal_impulse_conducting | 1.45367987 |
| 40 | MP0005165_increased_susceptibility_to | 1.44126043 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.39370828 |
| 42 | MP0002933_joint_inflammation | 1.38923360 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.37218712 |
| 44 | MP0000343_altered_response_to | 1.33062381 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.33059826 |
| 46 | * MP0002128_abnormal_blood_circulation | 1.32119274 |
| 47 | MP0008004_abnormal_stomach_pH | 1.26936340 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.26221984 |
| 49 | MP0005595_abnormal_vascular_smooth | 1.26095611 |
| 50 | MP0004147_increased_porphyrin_level | 1.24020173 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.21992713 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.21128674 |
| 53 | MP0002796_impaired_skin_barrier | 1.20846367 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.20819482 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.19797293 |
| 56 | MP0002925_abnormal_cardiovascular_devel | 1.19290309 |
| 57 | MP0000266_abnormal_heart_morphology | 1.19207290 |
| 58 | MP0005275_abnormal_skin_tensile | 1.18075480 |
| 59 | MP0005369_muscle_phenotype | 1.14797199 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.14752333 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.14696698 |
| 62 | MP0002249_abnormal_larynx_morphology | 1.10683405 |
| 63 | MP0002295_abnormal_pulmonary_circulatio | 1.10160276 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.09957239 |
| 65 | MP0002971_abnormal_brown_adipose | 1.05000917 |
| 66 | * MP0000249_abnormal_blood_vessel | 1.03929498 |
| 67 | * MP0001614_abnormal_blood_vessel | 1.02894035 |
| 68 | MP0000230_abnormal_systemic_arterial | 1.00442169 |
| 69 | MP0004858_abnormal_nervous_system | 1.00178950 |
| 70 | MP0004510_myositis | 0.99817196 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.99601732 |
| 72 | MP0000759_abnormal_skeletal_muscle | 0.97959963 |
| 73 | MP0004233_abnormal_muscle_weight | 0.96916002 |
| 74 | MP0005187_abnormal_penis_morphology | 0.96574226 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.92930245 |
| 76 | MP0009840_abnormal_foam_cell | 0.91432053 |
| 77 | MP0001851_eye_inflammation | 0.88623787 |
| 78 | MP0002269_muscular_atrophy | 0.83319919 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80175143 |
| 80 | MP0005501_abnormal_skin_physiology | 0.78660127 |
| 81 | * MP0001784_abnormal_fluid_regulation | 0.77511500 |
| 82 | MP0001915_intracranial_hemorrhage | 0.76677367 |
| 83 | MP0002108_abnormal_muscle_morphology | 0.76116109 |
| 84 | MP0009115_abnormal_fat_cell | 0.75431056 |
| 85 | MP0003011_delayed_dark_adaptation | 0.74140833 |
| 86 | MP0000049_abnormal_middle_ear | 0.73616020 |
| 87 | MP0003045_fibrosis | 0.73296562 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.72627850 |
| 89 | MP0003950_abnormal_plasma_membrane | 0.72321389 |
| 90 | MP0000747_muscle_weakness | 0.71633166 |
| 91 | MP0005360_urolithiasis | 0.70967151 |
| 92 | MP0001502_abnormal_circadian_rhythm | 0.68962495 |
| 93 | * MP0003948_abnormal_gas_homeostasis | 0.68239050 |
| 94 | MP0002932_abnormal_joint_morphology | 0.68136280 |
| 95 | MP0004883_abnormal_blood_vessel | 0.67875200 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.65789591 |
| 97 | MP0001849_ear_inflammation | 0.65781139 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.63921744 |
| 99 | MP0005164_abnormal_response_to | 0.63134814 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.62778618 |
| 101 | MP0003091_abnormal_cell_migration | 0.62352598 |
| 102 | MP0003303_peritoneal_inflammation | 0.61075433 |
| 103 | MP0005388_respiratory_system_phenotype | 0.60087723 |
| 104 | MP0002133_abnormal_respiratory_system | 0.60087723 |
| 105 | MP0005085_abnormal_gallbladder_physiolo | 0.58867809 |
| 106 | MP0001661_extended_life_span | 0.57897250 |
| 107 | MP0009278_abnormal_bone_marrow | 0.57828564 |
| 108 | MP0005451_abnormal_body_composition | 0.57584166 |
| 109 | MP0005023_abnormal_wound_healing | 0.57161848 |
| 110 | MP0000733_abnormal_muscle_development | 0.56613872 |
| 111 | MP0003385_abnormal_body_wall | 0.56454254 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.53605879 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.53455583 |
| 114 | MP0003252_abnormal_bile_duct | 0.53407537 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.51621885 |
| 116 | MP0005508_abnormal_skeleton_morphology | 0.50902938 |
| 117 | MP0005083_abnormal_biliary_tract | 0.50790951 |
| 118 | MP0003984_embryonic_growth_retardation | 0.50572591 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.50408679 |
| 120 | MP0002970_abnormal_white_adipose | 0.50218502 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.50097473 |
| 122 | MP0005334_abnormal_fat_pad | 0.49935063 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.48968688 |
| 124 | MP0003959_abnormal_lean_body | 0.48766518 |
| 125 | MP0009053_abnormal_anal_canal | 0.47986667 |
| 126 | MP0003935_abnormal_craniofacial_develop | 0.47527830 |
| 127 | MP0003075_altered_response_to | 0.47266015 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.46836514 |
| 129 | MP0008875_abnormal_xenobiotic_pharmacok | 0.46558753 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.46547239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.68043980 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.66390612 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.03036709 |
| 4 | Polycythemia (HP:0001901) | 4.91422542 |
| 5 | Increased connective tissue (HP:0009025) | 4.62256278 |
| 6 | Atrial fibrillation (HP:0005110) | 4.57870495 |
| 7 | Broad metatarsal (HP:0001783) | 4.33410440 |
| 8 | Primary atrial arrhythmia (HP:0001692) | 4.25959155 |
| 9 | Supraventricular arrhythmia (HP:0005115) | 4.24068853 |
| 10 | Supraventricular tachycardia (HP:0004755) | 4.07420301 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 3.95661121 |
| 12 | Lipoatrophy (HP:0100578) | 3.90550877 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 3.85707656 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.75369963 |
| 15 | Hematochezia (HP:0002573) | 3.60267520 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.60093924 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.52414802 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.50988462 |
| 19 | Exercise-induced myalgia (HP:0003738) | 3.32285438 |
| 20 | Esophageal varix (HP:0002040) | 3.31328574 |
| 21 | Subaortic stenosis (HP:0001682) | 3.26135083 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.26135083 |
| 23 | Syncope (HP:0001279) | 3.25145676 |
| 24 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23329888 |
| 25 | Atrioventricular block (HP:0001678) | 3.16708370 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.14975317 |
| 27 | Difficulty running (HP:0009046) | 3.14565146 |
| 28 | Abnormality of the calf musculature (HP:0001430) | 3.13756972 |
| 29 | Dilated cardiomyopathy (HP:0001644) | 3.11921676 |
| 30 | Cerebral hemorrhage (HP:0001342) | 3.09784186 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92602035 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 2.92191026 |
| 33 | Wrist flexion contracture (HP:0001239) | 2.91694539 |
| 34 | Pulmonary artery stenosis (HP:0004415) | 2.90012029 |
| 35 | Myotonia (HP:0002486) | 2.89392459 |
| 36 | Prolonged QT interval (HP:0001657) | 2.89054608 |
| 37 | Deep venous thrombosis (HP:0002625) | 2.88390380 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.85311138 |
| 39 | EMG: myopathic abnormalities (HP:0003458) | 2.84396162 |
| 40 | Myoglobinuria (HP:0002913) | 2.84351644 |
| 41 | Bundle branch block (HP:0011710) | 2.82628562 |
| 42 | Heart block (HP:0012722) | 2.82079246 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.80284358 |
| 44 | Palpitations (HP:0001962) | 2.76697194 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 2.73031068 |
| 46 | Visceral angiomatosis (HP:0100761) | 2.72675741 |
| 47 | Joint hemorrhage (HP:0005261) | 2.70279927 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.65749143 |
| 49 | Bulbar palsy (HP:0001283) | 2.64791475 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.64003122 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63516330 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.57996847 |
| 53 | Difficulty climbing stairs (HP:0003551) | 2.56307260 |
| 54 | Hemangiomatosis (HP:0007461) | 2.54455954 |
| 55 | Mesangial abnormality (HP:0001966) | 2.54208648 |
| 56 | Abnormality of the hepatic vasculature (HP:0006707) | 2.52195530 |
| 57 | Distal lower limb amyotrophy (HP:0008944) | 2.50726195 |
| 58 | Spinal rigidity (HP:0003306) | 2.49725017 |
| 59 | Acanthosis nigricans (HP:0000956) | 2.47886024 |
| 60 | Ventricular arrhythmia (HP:0004308) | 2.44729245 |
| 61 | Aneurysm (HP:0002617) | 2.41936105 |
| 62 | Muscle fiber inclusion bodies (HP:0100299) | 2.41355271 |
| 63 | Ventricular fibrillation (HP:0001663) | 2.40043359 |
| 64 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.38954134 |
| 65 | Neonatal death (HP:0003811) | 2.38295943 |
| 66 | Short 4th metacarpal (HP:0010044) | 2.37987037 |
| 67 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.37987037 |
| 68 | Stroke (HP:0001297) | 2.37945843 |
| 69 | Short hallux (HP:0010109) | 2.37724361 |
| 70 | Round ear (HP:0100830) | 2.35952185 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.35768961 |
| 72 | Cavernous hemangioma (HP:0001048) | 2.33807258 |
| 73 | * Nonimmune hydrops fetalis (HP:0001790) | 2.33296811 |
| 74 | Obstructive sleep apnea (HP:0002870) | 2.32932817 |
| 75 | Hypoplastic ischia (HP:0003175) | 2.31275809 |
| 76 | Abnormality of the 4th metacarpal (HP:0010012) | 2.31011003 |
| 77 | Nemaline bodies (HP:0003798) | 2.29499331 |
| 78 | Congenital, generalized hypertrichosis (HP:0004540) | 2.28108605 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.27065758 |
| 80 | Aortic dissection (HP:0002647) | 2.26415110 |
| 81 | Areflexia of lower limbs (HP:0002522) | 2.25026812 |
| 82 | Polygenic inheritance (HP:0010982) | 2.23927322 |
| 83 | Ankle contracture (HP:0006466) | 2.21540310 |
| 84 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.19168314 |
| 85 | Large for gestational age (HP:0001520) | 2.18879292 |
| 86 | Complement deficiency (HP:0004431) | 2.14747441 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12443772 |
| 88 | Hip contracture (HP:0003273) | 2.11543039 |
| 89 | Ketoacidosis (HP:0001993) | 2.11505150 |
| 90 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09974914 |
| 91 | Hydroureter (HP:0000072) | 2.09497193 |
| 92 | Abnormality of complement system (HP:0005339) | 2.09288869 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.09207784 |
| 94 | Abnormality of the ischium (HP:0003174) | 2.08936984 |
| 95 | Conjunctival telangiectasia (HP:0000524) | 2.07581314 |
| 96 | Rhabdomyolysis (HP:0003201) | 2.07574083 |
| 97 | Pigmentary retinal degeneration (HP:0001146) | 2.07118593 |
| 98 | Neck muscle weakness (HP:0000467) | 2.04801190 |
| 99 | Bladder diverticulum (HP:0000015) | 2.03981282 |
| 100 | Shallow orbits (HP:0000586) | 2.02787233 |
| 101 | Adactyly (HP:0009776) | 2.00129657 |
| 102 | Distal lower limb muscle weakness (HP:0009053) | 1.99889168 |
| 103 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.99389121 |
| 104 | Abnormality of the sella turcica (HP:0002679) | 1.98322453 |
| 105 | Fragile skin (HP:0001030) | 1.98287950 |
| 106 | Distal arthrogryposis (HP:0005684) | 1.96994159 |
| 107 | Muscle stiffness (HP:0003552) | 1.96736471 |
| 108 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96287867 |
| 109 | Growth hormone excess (HP:0000845) | 1.95967541 |
| 110 | Skull defect (HP:0001362) | 1.95848515 |
| 111 | Testicular atrophy (HP:0000029) | 1.94915417 |
| 112 | Absent hand (HP:0004050) | 1.94160258 |
| 113 | Vascular tortuosity (HP:0004948) | 1.92937038 |
| 114 | Hypertriglyceridemia (HP:0002155) | 1.92170947 |
| 115 | Milia (HP:0001056) | 1.91879029 |
| 116 | Abnormal EKG (HP:0003115) | 1.91825798 |
| 117 | Abnormality of the anterior chamber (HP:0000593) | 1.91519948 |
| 118 | Capillary hemangiomas (HP:0005306) | 1.90942924 |
| 119 | Porencephaly (HP:0002132) | 1.89641111 |
| 120 | * Lymphangioma (HP:0100764) | 1.88311540 |
| 121 | Atrophic scars (HP:0001075) | 1.87281495 |
| 122 | Hypoplasia of the iris (HP:0007676) | 1.83631488 |
| 123 | Facial diplegia (HP:0001349) | 1.83255793 |
| 124 | * Venous abnormality (HP:0002624) | 1.83217992 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.82562876 |
| 126 | Pulmonary hypertension (HP:0002092) | 1.81588728 |
| 127 | Ectopia lentis (HP:0001083) | 1.81191590 |
| 128 | Aortic aneurysm (HP:0004942) | 1.81168595 |
| 129 | Aortic valve stenosis (HP:0001650) | 1.81156885 |
| 130 | Congestive heart failure (HP:0001635) | 1.81020408 |
| 131 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80390559 |
| 132 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80214139 |
| 133 | Portal hypertension (HP:0001409) | 1.79472817 |
| 134 | Limb-girdle muscle atrophy (HP:0003797) | 1.79251066 |
| 135 | Axonal loss (HP:0003447) | 1.79222275 |
| 136 | * Venous insufficiency (HP:0005293) | 1.78685611 |
| 137 | Myopathic facies (HP:0002058) | 1.78660335 |
| 138 | Abnormality of the tricuspid valve (HP:0001702) | 1.78641177 |
| 139 | Neoplasm of the heart (HP:0100544) | 1.78300981 |
| 140 | Ulnar deviation of the wrist (HP:0003049) | 1.77065268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.65370315 |
| 2 | KDR | 8.12089719 |
| 3 | TGFBR2 | 3.61932843 |
| 4 | TTN | 2.53645655 |
| 5 | TGFBR1 | 2.31478075 |
| 6 | MYLK | 2.22945000 |
| 7 | EPHB2 | 2.02328764 |
| 8 | RIPK1 | 1.99887893 |
| 9 | TRIB3 | 1.89308165 |
| 10 | PKN2 | 1.79527098 |
| 11 | FES | 1.76843664 |
| 12 | ERN1 | 1.68675713 |
| 13 | DMPK | 1.59420364 |
| 14 | LMTK2 | 1.54996535 |
| 15 | PTK2B | 1.52385593 |
| 16 | GRK1 | 1.49021844 |
| 17 | PDK2 | 1.48011823 |
| 18 | TSSK6 | 1.45132262 |
| 19 | PHKG1 | 1.37838860 |
| 20 | PHKG2 | 1.37838860 |
| 21 | BCKDK | 1.32977734 |
| 22 | EPHB1 | 1.24253179 |
| 23 | PTK6 | 1.22727185 |
| 24 | FER | 1.17647039 |
| 25 | EEF2K | 1.08153710 |
| 26 | PRKD1 | 1.06395910 |
| 27 | PDGFRA | 1.04107495 |
| 28 | MAPK12 | 1.01427636 |
| 29 | PRPF4B | 0.96608177 |
| 30 | MAP3K6 | 0.96209368 |
| 31 | PDK3 | 0.94406317 |
| 32 | PDK4 | 0.94406317 |
| 33 | FGFR4 | 0.93816053 |
| 34 | TESK1 | 0.93776876 |
| 35 | INSRR | 0.91786616 |
| 36 | WNK4 | 0.91614049 |
| 37 | NTRK1 | 0.90612520 |
| 38 | MAP2K3 | 0.84023167 |
| 39 | CAMK4 | 0.82010137 |
| 40 | OBSCN | 0.81594588 |
| 41 | SIK1 | 0.79454996 |
| 42 | PIK3CA | 0.77662745 |
| 43 | PAK4 | 0.73832733 |
| 44 | MAP4K1 | 0.71105343 |
| 45 | PRKCH | 0.66205148 |
| 46 | TRPM7 | 0.65013893 |
| 47 | IRAK3 | 0.64548932 |
| 48 | PRKAA2 | 0.64465016 |
| 49 | PRKG2 | 0.64029528 |
| 50 | SMG1 | 0.63704938 |
| 51 | MAPK4 | 0.63126424 |
| 52 | CAMK1D | 0.62252805 |
| 53 | MAPK15 | 0.58127890 |
| 54 | EPHA2 | 0.57993487 |
| 55 | JAK1 | 0.57427610 |
| 56 | DDR2 | 0.56789998 |
| 57 | ARAF | 0.55995072 |
| 58 | MAP3K7 | 0.55225620 |
| 59 | LRRK2 | 0.54694385 |
| 60 | CAMK1G | 0.53989745 |
| 61 | MAP3K11 | 0.53177187 |
| 62 | ABL2 | 0.52925746 |
| 63 | MUSK | 0.52019681 |
| 64 | ZAP70 | 0.51834382 |
| 65 | MAP3K1 | 0.51478491 |
| 66 | RPS6KA2 | 0.51146410 |
| 67 | MAP3K10 | 0.50514519 |
| 68 | ILK | 0.50507223 |
| 69 | MAP3K3 | 0.49935933 |
| 70 | PRKD3 | 0.48659080 |
| 71 | PRKD2 | 0.48602070 |
| 72 | PAK3 | 0.47868809 |
| 73 | PTK2 | 0.47671263 |
| 74 | ROCK1 | 0.46732790 |
| 75 | AKT2 | 0.45161366 |
| 76 | FGFR2 | 0.44137591 |
| 77 | MAP2K1 | 0.43367372 |
| 78 | RPS6KC1 | 0.43240879 |
| 79 | RPS6KL1 | 0.43240879 |
| 80 | RET | 0.42836242 |
| 81 | JAK2 | 0.42108355 |
| 82 | MAPK7 | 0.41893580 |
| 83 | LATS1 | 0.39842799 |
| 84 | MOS | 0.39366123 |
| 85 | CSK | 0.39316828 |
| 86 | GRK7 | 0.39140801 |
| 87 | MAP2K2 | 0.38973186 |
| 88 | PDPK1 | 0.38417508 |
| 89 | LIMK1 | 0.38382958 |
| 90 | MET | 0.36460518 |
| 91 | ITK | 0.35880342 |
| 92 | TYRO3 | 0.35159092 |
| 93 | BMX | 0.34686169 |
| 94 | CDK9 | 0.34683196 |
| 95 | BLK | 0.34127705 |
| 96 | PRKAA1 | 0.34068141 |
| 97 | PRKCE | 0.33493607 |
| 98 | PINK1 | 0.32906680 |
| 99 | MAPKAPK3 | 0.32660249 |
| 100 | DAPK2 | 0.32418039 |
| 101 | CAMK1 | 0.31305657 |
| 102 | EPHA3 | 0.31216489 |
| 103 | FLT3 | 0.31056769 |
| 104 | NEK9 | 0.30747403 |
| 105 | MAP3K13 | 0.30710294 |
| 106 | PDGFRB | 0.30633273 |
| 107 | ICK | 0.30407479 |
| 108 | GSK3A | 0.30317380 |
| 109 | STK24 | 0.29857691 |
| 110 | SRC | 0.29513261 |
| 111 | AKT3 | 0.28620131 |
| 112 | IGF1R | 0.28378102 |
| 113 | DAPK3 | 0.27482645 |
| 114 | PAK2 | 0.26527221 |
| 115 | LATS2 | 0.26482310 |
| 116 | HIPK2 | 0.25827064 |
| 117 | CDK12 | 0.25784845 |
| 118 | GRK5 | 0.24934506 |
| 119 | STK39 | 0.24290767 |
| 120 | CDC42BPA | 0.24143908 |
| 121 | FGFR3 | 0.23936337 |
| 122 | EGFR | 0.22964089 |
| 123 | JAK3 | 0.22116186 |
| 124 | MTOR | 0.22005560 |
| 125 | MARK2 | 0.20976390 |
| 126 | TBK1 | 0.20563618 |
| 127 | ROCK2 | 0.20074156 |
| 128 | PKN1 | 0.19604545 |
| 129 | TEC | 0.19578175 |
| 130 | PRKACB | 0.17654257 |
| 131 | CAMK2D | 0.16042194 |
| 132 | RPS6KA6 | 0.13960676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.37988213 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.89089472 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.63957474 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.62348381 |
| 5 | Prion diseases_Homo sapiens_hsa05020 | 2.59558241 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56272397 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.35264174 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28077731 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.18732566 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09840262 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.09511744 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98072835 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.97124798 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94419678 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.93753778 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93450041 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79079805 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59673880 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.55720144 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47031187 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45394881 |
| 22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.41605698 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.37195129 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36963879 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.35853383 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29931977 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29154615 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28768281 |
| 29 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.28116355 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22994573 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.22417748 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21911314 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.20562542 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16913774 |
| 35 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.16815436 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16034259 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09120528 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.06499186 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06070292 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02731955 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02726271 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 0.97743768 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97703071 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97345943 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97255042 |
| 46 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.96843240 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.95949256 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94389327 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92630667 |
| 50 | Malaria_Homo sapiens_hsa05144 | 0.92576752 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92222268 |
| 52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91631521 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.90153150 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90117522 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89254748 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88528499 |
| 57 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.87261443 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84813478 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83315427 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83260443 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80877679 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.80830007 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80271352 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80110146 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79396932 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78283083 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78159232 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77941053 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.77114748 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.76586049 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75549227 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73140265 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73081639 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70477944 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69791651 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.67940847 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66937145 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66554693 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66065387 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.65994520 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65413899 |
| 82 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64686399 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64414612 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63168663 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.63135888 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62647553 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62537514 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61540992 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60901653 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60018696 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.59986351 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.59874057 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59280336 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58434332 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58314689 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58013642 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57986156 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57596605 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.56721318 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54296951 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54280473 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53438299 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51106647 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50459859 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48426270 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47140915 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46439774 |
| 108 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46146641 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46009157 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45270062 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45152402 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45001870 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44943997 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44408196 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43774826 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42531435 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42264605 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41939222 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41559094 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41273564 |
| 121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41202079 |
| 122 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40330975 |
| 123 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40242713 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38694879 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37996260 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37450984 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36416807 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36280898 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34504629 |
| 130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32982018 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.31669956 |

